STAT20h
Using lab-grown human mini-brains, scientists find links between head trauma, herpes, and Alzheimer’s
Research published Tuesday is the first to connect the dots between a common herpes virus, head injury, and Alzheimer's.
This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly
Eli Lilly ( LLY 1.07%) and Novo Nordisk ( NVO -1.99%) are two of the most valuable healthcare stocks in the world, largely ...
Why Alzheimer’s Scientists Are Re-thinking the Amyloid Hypothesis
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
Hosted on MSN4h
Alzheimer’s disease cases in 8MM to reach 22.51 million by 2033
China is expected to witness the highest prevalence with an estimated 10.4 million cases. The total prevalent cases of ...
Seth Rogen and Wife Lauren Miller Recall ‘Brutal’ Time Navigating Her Mother’s Alzheimer’s in New Doc (Exclusive)
I've seen firsthand how people sharing their stories is very therapeutic and allows other people to open up themselves,” Seth ...
Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease
Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to posdinemab, a phosphorylated tau-directed monoclonal antibody (mAb) ...
Johnson & Johnson Gets FDA Fast-Track Designation for Posdinemab in Alzheimer's
The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...
When Head Trauma Wakes Dormant Viruses: A Hidden Risk for Alzheimer’s
A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...
IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer’s Agitation “CALMA” and Expands Recruitment Strategy
POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
Hosted on MSN23h
Aging plays a new role in the fight against Alzheimer's disease
The balance of protein health within cells, a process known as proteostasis, is critical for maintaining cellular ...
Early Signs of Alzheimer's Women Should Not Ignore, According to Neurology Expert
Alzheimer’s disease is the most common cause of dementia in older adults. But according to experts, the condition affects men ...